Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Poisoning by co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Intentional paracetamol overdose |
Causative agent |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Deliberate overdose of co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol blood measurement |
Component |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
Serum paracetamol measurement |
Component |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
Accidental paracetamol poisoning (disorder) |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Intentional paracetamol poisoning |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
forgiftning med paracetamol, uvist med hvilken hensigt |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
1 |
forgiftning med co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
accidentel forgiftning med co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
tilsigtet forgiftning med co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
forgiftning med co-proxamol, uvist med hvilken hensigt |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
Accidental poisoning by co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Intentional poisoning by co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Poisoning by co-proxamol of undetermined intent |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Adverse reaction caused by paracetamol |
Causative agent |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Allergy to paracetamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol overdose |
Causative agent |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Accidental paracetamol overdose |
Causative agent |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
overdosis af paracetamol, uvist med hvilken hensigt |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
1 |
overdosis af paracetamol og dextropropoxyphen |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
accidentel overdosis af paracetamol og dextropropoxyphen |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
1 |
tilsigtet overdosis af paracetamol og dextropropoxyphen |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
overdosis af paracetamol og dextropropoxyphen, uvist med hvilken hensigt |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
Overdose of co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Accidental overdose by co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Overdose of co-proxamol of undetermined intent |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
allergi over for co-proxamol |
Causative agent |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 500 mg opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 100 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 240 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 60 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 125 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol sukkerfri oral opløsning 120 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 120 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 250 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol sukkerfri suspension 500 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 120 mg opløselig tablet til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 80 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 325 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 80 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 325 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 160 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol dråber 80 mg/0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol eliksir 80 mg/2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol eliksir 80 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol eliksir 160 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 500 mg/15 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 48.2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen + chloralantipyrine + isometheptene mucate (1:1) 325mg/100mg/65mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 500 mg + chlorpheniraminmaleat 8 mg + phenylephrinhydrochlorid 40 mg kapselformet tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 120 mg + alkohol 7%v v + codeinphosphat 12 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 120 mg + codeinphosphat 12 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 15 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol 500 mg + oxycodonhydrochlorid 5 mg kapselformet tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol + pentazocinhydrochlorid kapselformet 650 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen 125mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen 120mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
paracetamol væske 160 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen 250mg oro-dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Paracetamol 1g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Acetaminophen measurement |
Component |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Acetaminophen measurement, urine |
Component |
False |
Paracetamol |
Inferred relationship |
Some |
2 |
Poisoning caused by paracetamol |
Causative agent |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Product containing paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Some |
1 |
Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Methionine 250 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
co-codamol 8 mg + 500 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
co-proxamol 32,5 mg + 325 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
acetaminophen+dextropropoxyphenhydrochlorid sukkerfri suspension 325 mg/32,5mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|
Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Paracetamol |
Inferred relationship |
Some |
|